Pharma Focus Asia

Aurobindo Pharma USA Invests $31.7 million to Establish National Headquarters in Durham, North Carolina

Introduction:

The New Jersey-based Aurobindo Pharma USA maker of generic pharmaceuticals plans to invest over $31.7 million in a new state-of-the-art national headquarters for specialty pharmaceutical R&D.

Features:

Aurobindo Pharma USA will establish a new R&D and manufacturing center in Durham. This investment will bring 275 new R&D and pharma-manufacturing jobs to Durham, North Carolina.

The company currently employs 14 scientists/workers in Raleigh. Among the new employees will be researchers, analytical chemists, production operators, quality control specialists and others.

We are very excited about our plans for expansion of our specialty pharma R&D and manufacturing in North Carolina, and are thankful to EDPNC, Durham City, Durham County and the State of North Carolina for supporting our decision. North Carolina has one of the best talent pools in the specialty pharma R&D and manufacturing sectors, and we look forward to establishing a large and successful footprint here said Dr. Ninad Deshpanday, President, R&D, Aurobindo Pharma USA, Inc.

Specifications:

NameAurobindo Pharma USA, Inc.
LocationDurham, North Carolina
TypeNew Headquarters
Estimated Cost$31.7 Million
Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024ISPE Singapore Affiliate Conference & Exhibition 2024Rehab Expo 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024